K&L GATES, LLP for CANGENE CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2010 | $40,000 | Replaced |
| 3rd Quarter - Amendment | Jun 10, 2011 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Matters generally related to biomedical vaccines, biomedical therapeutics, biodefense, and pandemic preparedness; general interest in H.R. 5498, the WMD Prevention and Preparedness Act of 2010; section 4155 of the House amendment to the Senate-passed version of H.R. 4899 which would have transferred funding out of the BioShield Special Reserve Fund.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE SWEENEY ANTHONY | — |
| SUSAN GEIGER | — |
| CHRISTOPHER HOPFENSPERGER | — |
| JAMES T WALSH New | U. S. Congressman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.